Berkeley, CA · Founded 2016 · Privately Held (backing)
Developer of a bioprinting technology designed to recreate and engineer human tissues in vitro. Prellis Biologics is based in Berkeley, CA and was founded in 2016. It was valued at $110 million at its later-stage round in Nov 2023, the last priced event on record. It has raised $70.2 million across 5 recorded rounds; the latest was a $17 million early-stage round in Jun 2022.
PMV mark · valuation
$110.1M
Oct 2026
Priced at
its later-stage round
Nov 2023
Total raised
$70.2M
Last round
Early Stage VC
Jun 2022
Cap table — not yet on record
Prellis Biologics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Prellis Biologics with a free account
·The complete investor list: 16 names
·Watch Prellis Biologics: the Monday email on marks, rounds and moves
Where does Prellis Biologics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Prellis Biologics's 5 recorded funding rounds.
